RecruitingNot ApplicableNCT06443970

Low and High Flow Suctioning in Intubated Infants

Physiological Consequences of Low and High Flow Endotracheal Suctioning Devices in Intubated Preterm and Term Infants


Sponsor

Columbia University

Enrollment

30 participants

Start Date

Sep 4, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Preterm and term intubuted infants in the NICU will undergo two sequential suctioning procedures: a new, FDA-approved suction device called EXSALTA (ED) and the standard conventional wall (SCW). The physiological consequences, i.e. changes in heart rate (HR), oxygen saturation (SpO2), cerebral oxygenation (C-rSO2), and cerebral fractional oxygen extraction (C-FOE) between ED and SCW ETT tracheal suctioning system in both open and closed catheter system settings will be evaluated using a randomized cross over design in preterm and term infants receiving mechanical ventilation via an ETT. This study will evaluate the hypothesis that there will be significantly lower variations in HR, SpO2, C-rSO2, and C-FOE during ETT suctioning with ED compared to SCW suctioning systems under both open and close ETT suction settings.


Eligibility

Max Age: 28 Days

Inclusion Criteria1

  • Preterm and term infants with birth weight more than 1000g receiving ETT suctioning

Exclusion Criteria1

  • Infants with cyanotic congenital heart disease and cardiac rhythm disorders (arrythmias) will be excluded from the study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEExsalta Suction Device

Low flow endotracheal suction device


Locations(1)

Columbia University Irving Medical Center

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06443970


Related Trials